BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7810169)

  • 1. Changes in content of P450 isozymes in hepatic and renal microsomes of the male rat treated with cis-diamminedichloroplatinum.
    Ohishi N; Imaoka S; Funae Y
    Xenobiotica; 1994 Sep; 24(9):873-80. PubMed ID: 7810169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the anticancer dehydrotarplatin on cytochrome P450 and antioxidant enzymes in male rat tissues.
    Nannelli A; Messina A; Marini S; Trasciatti S; Longo V; Gervasi PG
    Arch Toxicol; 2007 Jul; 81(7):479-87. PubMed ID: 17364183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin-induced diabetes.
    Shimojo N; Ishizaki T; Imaoka S; Funae Y; Fujii S; Okuda K
    Biochem Pharmacol; 1993 Aug; 46(4):621-7. PubMed ID: 8363636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P-450-dependent metabolism of lauric acid in alcoholic liver disease: comparison between rat liver and kidney microsomes.
    Amet Y; Lucas D; Zhang-Gouillon ZQ; French SW
    Alcohol Clin Exp Res; 1998 Apr; 22(2):455-62. PubMed ID: 9581653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. cis-Diamminedichloroplatinum induces peroxisomes as well as CYP4A1 in rat kidney.
    Nakamura M; Imaoka S; Tanaka E; Misawa S; Funae Y
    Res Commun Mol Pathol Pharmacol; 1998 Jan; 99(1):23-32. PubMed ID: 9523352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dioxane on cytochrome P450 enzymes in liver, kidney, lung and nasal mucosa of rat.
    Nannelli A; De Rubertis A; Longo V; Gervasi PG
    Arch Toxicol; 2005 Feb; 79(2):74-82. PubMed ID: 15490126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic ethanol on growth hormone secretion and hepatic cytochrome P450 isozymes of the rat.
    Badger TM; Ronis MJ; Lumpkin CK; Valentine CR; Shahare M; Irby D; Huang J; Mercado C; Thomas P; Ingelman-Sundberg M
    J Pharmacol Exp Ther; 1993 Jan; 264(1):438-47. PubMed ID: 8423543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved separation and immunodetection of rat cytochrome P450 4A forms in liver and kidney.
    Okita JR; Johnson SB; Castle PJ; Dezellem SC; Okita RT
    Drug Metab Dispos; 1997 Aug; 25(8):1008-12. PubMed ID: 9280410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega- and (omega-1)-hydroxylation of lauric acid and arachidonic acid by rat renal cytochrome P-450.
    Imaoka S; Tanaka S; Funae Y
    Biochem Int; 1989 Apr; 18(4):731-40. PubMed ID: 2504167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endotoxemia in rats is associated with induction of the P4504A subfamily and suppression of several other forms of cytochrome P450.
    Sewer MB; Koop DR; Morgan ET
    Drug Metab Dispos; 1996 Apr; 24(4):401-7. PubMed ID: 8801054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of rat hepatic cytochrome P450 enzymes by myristicin.
    Jeong HG; Yun CH
    Biochem Biophys Res Commun; 1995 Dec; 217(3):966-71. PubMed ID: 8554622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of CYP4A expression in rat by dehydroepiandrosterone and thyroid hormone.
    Webb SJ; Xiao GH; Geoghegan TE; Prough RA
    Mol Pharmacol; 1996 Feb; 49(2):276-87. PubMed ID: 8632760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450-dependent monooxygenase activities and their inducibility by classic P450 inducers in the liver, kidney, and nasal mucosa of male adult ring-necked pheasants.
    Giorgi M; Marini S; Longo V; Mazzaccaro A; Amato G; Gervasi PG
    Toxicol Appl Pharmacol; 2000 Sep; 167(3):237-45. PubMed ID: 10986015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of "male-specific" cytochrome P450 isozymes in female rats by oxandrolone.
    Waskiewicz MJ; Choudhuri S; Vanderbeck SM; Zhang XJ; Thomas PE
    Drug Metab Dispos; 1995 Nov; 23(11):1291-6. PubMed ID: 8591733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical characterization of lauric acid omega-hydroxylation by a CYP4A1/NADPH-cytochrome P450 reductase fusion protein.
    Chaurasia CS; Alterman MA; Lu P; Hanzlik RP
    Arch Biochem Biophys; 1995 Feb; 317(1):161-9. PubMed ID: 7872779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal tumorigenicity of 1,1-dichloroethene in mice: the role of male-specific expression of cytochrome P450 2E1 in the renal bioactivation of 1,1-dichloroethene.
    Speerschneider P; Dekant W
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):48-56. PubMed ID: 7839370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of hepatic drug metabolism by the interferon inducer, polyriboinosinic acid:polyribocitidylic acid.
    Sakai H; Okamoto T; Kikkawa Y
    J Pharmacol Exp Ther; 1992 Oct; 263(1):381-6. PubMed ID: 1403800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Participation of P450 3A enzymes in rat hepatic microsomal retinoic acid 4-hydroxylation.
    Martini R; Murray M
    Arch Biochem Biophys; 1993 May; 303(1):57-66. PubMed ID: 8489266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of rat hepatic microsomal cytochromes P450 by cyclophosphamide is correlated with plasma thyroid hormone levels and displays differential strain sensitivity.
    Kraner JC; Morgan ET; Poet TS; Born SL; Burnett VL; Halpert JR
    J Pharmacol Exp Ther; 1996 Jan; 276(1):258-64. PubMed ID: 8558440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of CYP4A11 as the major lauric acid omega-hydroxylase in human liver microsomes.
    Powell PK; Wolf I; Lasker JM
    Arch Biochem Biophys; 1996 Nov; 335(1):219-26. PubMed ID: 8914854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.